Dr Matthew Penny graduated in Chemistry for Drug Discovery from The University of Bath in 2007 followed by a PhD at University College London, under the supervision of Professor William B. Motherwell, working on enolate directed carbometallation. He then spent two years as a postdoctoral researcher at Imperial College London in the group of Professor Anthony G. M. Barrett working towards the synthesis of Cyclohexamantane. Following a year teaching Chemistry in an independent school, Matthew returned to research to join the Hilton group in January 2015. He is currently working on medical and synthetic applications of 3D printing and developing new ways to incorporate drugs into plastics.
Despite the enormous growth in 3D printing and its applications within chemical sciences, it still remains difficult to incorporate drugs into plastics. The current route, utilizing Hot Melt Extrusion (HME), involves heating an API with a plastic for a prolonged period of time to efficiently mix the two substances together leading to molecule degradation. We are currently looking at alternatives which would avoid undesirable heat cycles.